Jeffrey H. Cooper, SVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 5,905 shares at $38.00 ($224K) on 2008-02-29, disclosed to the SEC on 2008-03-04.
Open-market sale of $224k BMRN by SVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.82 | 300 | $11K | 5.1% |
| 2 | $37.89 | 500 | $19K | 8.5% |
| 3 | $37.92 | 1,800 | $68K | 30.5% |
| 4 | $37.96 | 1,100 | $42K | 18.6% |
| 5 | $37.97 | 800 | $30K | 13.6% |
| 6 | $37.98 | 300 |
| $11K |
| 5.1% |
| 7 | $37.99 | 600 | $23K | 10.2% |
| 8 | $38.00 | 405 | $15K | 6.9% |
| 9 | $38.01 | 100 | $4K | 1.7% |
| Total | $37.94 avg | 5,905 | $224K | 100% |
| Filing → |
| BMRN | SELL | 2012-01-05 | $87K | — | Filing → |
| BMRN | SELL | 2011-11-03 | $83K | — | Filing → |
| BMRN | SELL | 2011-10-11 | $625K | — | Filing → |